{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-103175","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2023-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.895136+00:00","generated_at":"2026-06-10T09:38:01.291434+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ReShape Lifesciences signs exclusive license for Obalon balloon in South Asia","bullets":["Exclusive license to Biorad Medysis for Obalon balloon in India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, Maldives.","$200,000 upfront plus 4% royalty on gross sales.","Biorad to become exclusive worldwide manufacturer under future supply agreement.","Territory covers ~20-25% of world population (~1.6-2 billion people)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-103175","json":"https://secwatch.observer/filing/0001104659-23-103175.json","markdown":"https://secwatch.observer/filing/0001104659-23-103175.md","text":"https://secwatch.observer/filing/0001104659-23-103175.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923103175/0001104659-23-103175-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923103175/tm2326688d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:38:01.291434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"642127eca1f3c8fa6087ebe593068efd6a356250","claim":"Vyome Holdings, Inc entered into License Agreement with Biorad Medysis Pvt. Ltd. valued at $200,000 in upfront payments (effective 2023-09-19).","evidence_excerpt":"On September 19, 2023, ReShape Lifesciences Inc. (the “Company”) entered into an Exclusive License Agreement (the “License Agreement”) with Biorad Medysis Pvt. Ltd. (“Biorad”), pursuant to which the Company granted an exclusive license to Biorad to manufacture, commercialize and distribute the Company’s Obalon® Gastric Balloon System in the territory of India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, and the Maldives.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000110465923103175/0001104659-23-103175-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Biorad Medysis Pvt. Ltd."},{"label":"Value","value":"$200,000 in upfront payments"},{"label":"Effective","value":"2023-09-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}